1. Malaysia's NPRA compares safety of two aflibercept products

   News item 25 February 2017 Pages: 1 - 1

2. Package inserts revised for vemurafenib, hydroxyzine in Japan

   News item 25 February 2017 Pages: 2 - 2

3. PRAC concludes safety review and initiates two new ones

   News item 25 February 2017 Pages: 3 - 3

4. Risk of serious skin burns with topical OTC pain relievers

   News item 25 February 2017 Pages: 4 - 4

5. TGA consultations for OTC NSAIDs and ibuprofen/paracetamol

   News item 25 February 2017 Pages: 5 - 5

6. Acute kidney injury related to high tacrolimus levels

   Clinical study 25 February 2017 Pages: 6 - 6

7. Hydroxychloroquine retinopathy in Korean patients

   Clinical study 25 February 2017 Pages: 7 - 7

8. Immediate hypersensitivity reactions during anaesthesia

   Clinical study 25 February 2017 Pages: 8 - 8

9. Medication for depression: morbidity and mortality

   Clinical study 25 February 2017 Pages: 9 - 9

10. Oxycodone/naloxone not linked with higher risk of MI, stroke

    Clinical study 25 February 2017 Pages: 10 - 10

11. Rituximab infusion-related reactions: clinical prediction model

    Clinical study 25 February 2017 Pages: 11 - 11

12. Vaccine adverse events in varying health system types

    Clinical study 25 February 2017 Pages: 12 - 12

13. Abacavir

    Case report 25 February 2017 Pages: 13 - 13

14. Abacavir/dolutegravir/lamivudine

    Case report 25 February 2017 Pages: 14 - 14

15. Abiraterone

    Case report 25 February 2017 Pages: 15 - 15

16. Abiraterone/zoledronic acid

    Case report 25 February 2017 Pages: 16 - 16

17. Adalimumab

    Case report 25 February 2017 Pages: 17 - 17

18. Adalimumab/etanercept

    Case report 25 February 2017 Pages: 18 - 18

19. Adalimumab/etanercept

    Case report 25 February 2017 Pages: 19 - 19

20. Aflibercept/fluorouracil/irinotecan

    Case report 25 February 2017 Pages: 20 - 20

21. Albumin human

    Case report 25 February 2017 Pages: 21 - 21

22. Alcohol/bleomycin

    Case report 25 February 2017 Pages: 22 - 22

23. Alemtuzumab/methylprednisolone

    Case report 25 February 2017 Pages: 23 - 23

24. Alendronic acid/zoledronic acid

    Case report 25 February 2017 Pages: 24 - 24

25. Alendronic-acid and ibandronic-acid

    Case report 25 February 2017 Pages: 25 - 25

26. Alfacalcidol/methyldopa

    Case report 25 February 2017 Pages: 26 - 26

27. Alprostadil

    Case report 25 February 2017 Pages: 27 - 27

28. Alteplase/heparin

    Case report 25 February 2017 Pages: 28 - 28

29. Amfetamine/methylenedioxymetamfetamine

    Case report 25 February 2017 Pages: 29 - 29

30. Amiodarone

    Case report 25 February 2017 Pages: 30 - 30

31. Amiodarone/iobitridol

    Case report 25 February 2017 Pages: 31 - 31

32. Amitriptyline

    Case report 25 February 2017 Pages: 32 - 32

33. Amoxicillin/clavulanic acid

    Case report 25 February 2017 Pages: 33 - 33

34. Anastrozole

    Case report 25 February 2017 Pages: 34 - 34

35. Anti-CD19-CAR transduced T-cells/anti-B-cell maturation antigen receptor T-cells

    Case report 25 February 2017 Pages: 35 - 35

36. Anti-egfr-car-transduced-t-cells/nivolumab

    Case report 25 February 2017 Pages: 36 - 36

37. Antineoplastics

    Case report 25 February 2017 Pages: 37 - 37

38. Antineoplastics

    Case report 25 February 2017 Pages: 38 - 38

39. Antineoplastics

    Case report 25 February 2017 Pages: 39 - 39

40. Antineoplastics

    Case report 25 February 2017 Pages: 40 - 40

41. Antineoplastics

    Case report 25 February 2017 Pages: 41 - 41

42. Antineoplastics and doxorubicin

    Case report 25 February 2017 Pages: 42 - 42

43. Antineoplastics/ciprofloxacin/filgrastim

    Case report 25 February 2017 Pages: 43 - 43

44. Antipsychotics

    Case report 25 February 2017 Pages: 44 - 44

45. Antipsychotics/tadalafil/tramadol

    Case report 25 February 2017 Pages: 45 - 45

46. Antiretrovirals

    Case report 25 February 2017 Pages: 46 - 46

47. Antiretrovirals/dexamethasone

    Case report 25 February 2017 Pages: 47 - 47

48. Antiretrovirals/ledipasvir/sofosbuvir

    Case report 25 February 2017 Pages: 48 - 48

49. Antithymocyte globulin

    Case report 25 February 2017 Pages: 49 - 49

50. Antituberculars

    Case report 25 February 2017 Pages: 50 - 50